10 Treatment sequelae and quality of life

Aaronson, 1993, The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, Journal of the National Cancer Institute, 85, 365, 10.1093/jnci/85.5.365 Abrahamsen, 1993, Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time and age, Journal of Clinical Oncology, 11, 255, 10.1200/JCO.1993.11.2.255 Aisner, 1993, Pregnancy outcome in patients treated for Hodgkin's disease, Journal of Clinical Oncology, 11, 507, 10.1200/JCO.1993.11.3.507 Amstrong, 1990, Infectious complications of Hodgkin's disease, 151 Andrieu, 1990, Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease, Journal of Clinical Oncology, 8, 1148, 10.1200/JCO.1990.8.7.1148 Beaty, 1995, Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease, Journal of Clinical Oncology, 13, 603, 10.1200/JCO.1995.13.3.603 Bennett, 1991, Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience, Annals of Oncology, 2, 83 Biti, 1994, Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution, International Journal of Radiation Oncology Biology and Physics, 29, 25, 10.1016/0360-3016(94)90222-4 Björkholm, 1990, Immunocompetence in patients with Hodgkin's disease, 112 Blayney, 1987, Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease, New England Journal of Medicine, 316, 710, 10.1056/NEJM198703193161203 Boffetta, 1994, Secondary malignancies following cancer chemotherapy, Acta Oncologica, 33, 591, 10.3109/02841869409121767 Boivin, 1982, Coronary heart disease mortality after irradiation for Hodgkin's disease, Cancer, 49, 2470, 10.1002/1097-0142(19820615)49:12<2470::AID-CNCR2820491210>3.0.CO;2-Y Boivin, 1995, Incidence of second cancers in patients treated for Hodgkin's disease, Journal of the National Cancer Institute, 87, 732, 10.1093/jnci/87.10.732 Bonfante, 1995, Fertility evaluation in patients with Hodgkin's disease, 88 Bookman, 1986, Concomitant illness in patients treated for Hodgkin's disease, Cancer Treatment Reviews, 13, 77, 10.1016/0305-7372(86)90015-0 Brämswig, 1990, The effects of different cumulative doses of chemotherapy on testicular function, Cancer, 65, 1298, 10.1002/1097-0142(19900315)65:6<1298::AID-CNCR2820650607>3.0.CO;2-W Brusamolino, 1995, Myelodysplasia and leukemia in Hodgkin's disease are related to age, splenectomy, and combined radio-chemotherapy with MOPP and nitrosoureas, 222 Byrne, 1989, Marriage and divorce after childhood and adolescent cancer, Journal of the American Medical Association, 17, 2693, 10.1001/jama.1989.03430190077035 Cella, 1986, Psychological adjustment to survival from Hodgkin's disease, Journal of Consulting and Clinical Psychology, 54, 616, 10.1037/0022-006X.54.5.616 Charak, 1990, Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease, Cancer, 65, 1903, 10.1002/1097-0142(19900501)65:9<1903::AID-CNCR2820650905>3.0.CO;2-# Clark, 1995, Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen, Journal of Clinical Oncology, 13, 134, 10.1200/JCO.1995.13.1.134 Coia, 1988, Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's diseases and seminoma, International Journal of Radiation Oncology Biology and Physics, 15, 29, 10.1016/0360-3016(88)90343-4 Corn, 1990, Irradiation-related ischemic heart disease, Journal of Clinical Oncology, 8, 741, 10.1200/JCO.1990.8.4.741 Cosset, 1991, Long-term toxicity of early stages Hodgkin's disease therapy: the EORTC experience, Annals of Oncology, 2, 77 Cosset, 1988, Late injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation, Radiotherapy and Oncology, 13, 61, 10.1016/0167-8140(88)90299-X Cosset, 1991, Pericarditis and myocardial infarctions after Hodgkin's disease therapy at the Institut Gustave Roussy, International Journal of Radiation Oncology Biology and Physics, 21, 447, 10.1016/0360-3016(91)90794-5 Derogatis, 1983, The prevalence of psychiatric disorders among cancer patients, Journal of the American Medical Association, 249, 751, 10.1001/jama.1983.03330300035030 Desablens, 1995, Hypothyroidism after Hodgkin's disease. Pathogenic hypothesis from a study of 51 patients treated by 3 courses of the ABVD-MP regimen and 40 Gy radiotherapy, 117 Devereux, 1990, Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation, British Medical Journal, 301, 1077, 10.1136/bmj.301.6760.1077 Devlen, 1987, Psychological problems associated with diagnosis and treatment of lymphomas: prospective study, British Medical Journal, 295, 955, 10.1136/bmj.295.6604.955 Dietrich, 1993, Linitis plastica after Hodgkin's disease, Lancet, 342, 57, 10.1016/0140-6736(93)91926-D Dietrich, 1994, Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?, Blood, 84, 1209, 10.1182/blood.V84.4.1209.1209 Dubray, 1995, Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation, Radiotherapy and Oncology, 36, 211, 10.1016/0167-8140(95)01606-H Ell, 1989, A longitudinal analysis of psychological adaptation among survivors of cancer, Cancer, 36, 406, 10.1002/1097-0142(19890115)63:2<406::AID-CNCR2820630234>3.0.CO;2-2 Fobair, 1986, Psychosocial problems among survivors of Hodgkin's disease, Journal of Clinical Oncology, 4, 805, 10.1200/JCO.1986.4.5.805 Gerling, 1990, Cardiovascular complications of the treatment of Hodgkin's disease, 267 Goodwin, 1987, The effect of marital status on stage, treatment and survival of cancer patients, Journal of the American Medical Association, 258, 3125, 10.1001/jama.1987.03400210067027 Gustavsson, 1990, Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease, Annals of Oncology, 1, 355, 10.1093/oxfordjournals.annonc.a057774 Gustavsson, 1992, Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease, Annals of Oncology, 3, 455, 10.1093/oxfordjournals.annonc.a058234 Hancock, 1988, Intercurrent death after Hodgkin's disease therapy in radiotherapy and adjuvant MOPP trials, Annals of Internal Medicine, 109, 183, 10.7326/0003-4819-109-3-183 Hancock, 1991, Death after treatment of Hodgkin's disease, Annals of Internal Medicine, 114, 810, 10.7326/0003-4819-114-9-810 Hancock, 1991, Thyroid diseases after treatment of Hodgkin's disease, New England Journal of Medicine, 325, 599, 10.1056/NEJM199108293250902 Hancock, 1993, Factors affecting late mortality from heart disease after treatment of Hodgkin's disease, Journal of the American Medical Association, 270, 1949, 10.1001/jama.1993.03510160067031 Hancock, 1993, Breast cancer after treatment of Hodgkin's disease, Journal of the National Cancer Institute, 85, 25, 10.1093/jnci/85.1.25 Hellman, 1978, The place of radiation therapy in the treatment of Hodgkin's disease, Cancer, 42, 971, 10.1002/1097-0142(197808)42:2+<971::AID-CNCR2820420720>3.0.CO;2-I Henry-Amar, 1988, Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease, National Cancer Institute Monograph, 6, 65 Henry-Amar, 1992, Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease, Annals of Oncology, 3, S117, 10.1093/annonc/3.suppl_4.S117 Henry-Amar, 1993, Acute leukemia after the treatment of Hodgkin's disease, Hematology/Oncology Clinics of North America, 7, 369, 10.1016/S0889-8588(18)30246-6 Henry-Amar, 1990, Survival outcome after Hodgkin disease: a report of the International Data Base on Hodgkin's Disease, 17, 758 Henry-Amar, 1990, Long term survival in early stages Hodgkin disease: the EORTC experience, vol. 196, 151 Henry-Amar, 1989, Risk of secondary acute leukemia and pre-leukemia after Hodgkin's disease: the Institut Gustave Roussy experience, Recent Results in Cancer Research, 117, 270, 10.1007/978-3-642-83781-4_30 Hill, 1995, Evaluation of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity, Journal of Clinical Oncology, 13, 387, 10.1200/JCO.1995.13.2.387 Hoerni, 1986, Retentissement psychosocial du traitement de la maladie de Hodgkin: appréciation par questionnaire auprès de 150 malades, Bulletin du Cancer (Paris), 73, 620 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1987, vol. 1–42 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1991, vol. 50 Jockovich, 1994, Long-term complications of laparotomy in Hodgkin's disease, Annals of Surgery, 219, 615, 10.1097/00000658-199406000-00004 Joly, 1996, Late psychosocial sequelae in Hodgkin's disease survivors: a French population based case-control study, Journal of Clinical Oncology, 10.1200/JCO.1996.14.9.2444 Kaldor, 1987, Second malignancies following testicular cancer, ovarian cancer, and Hodgkin's disease: an international collaborative study among cancer registries, International Journal of Cancer, 39, 571, 10.1002/ijc.2910390506 Kaldor, 1990, Leukemia following Hodgkin's disease, New England Journal of Medicine, 322, 7, 10.1056/NEJM199001043220102 Kaldor, 1992, Lung cancer following Hodgkin's disease: a case-control study, International Journal of Cancer, 52, 677, 10.1002/ijc.2910520502 Kaplan, 1973, Complications of intensive megavoltage radiotherapy for Hodgkin's disease, National Cancer Institute Monograph, 36, 439 Kluin-Nelemans, 1995, Assessment of thyroid, pulmonary, cardiac and gonadal toxicity in stages I–II Hodgkin's disease, 90 Kornblith, 1992, Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation, Cancer, 70, 2214, 10.1002/1097-0142(19921015)70:8<2214::AID-CNCR2820700833>3.0.CO;2-X Krikorian, 1979, Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease, New England Journal of Medicine, 300, 452, 10.1056/NEJM197903013000902 Land, 1990, A Nested Case-Control Approach to Interactions Between Radiation Dose and Other Factors as Causes of Cancer Mah, 1994, Quantitative effects of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study, International Journal of Radiation Oncology Biology and Physics, 28, 563, 10.1016/0360-3016(94)90180-5 Mauch, 1994, Controversies in the management of early stage Hodgkin's disease, Blood, 83, 318, 10.1182/blood.V83.2.318.318 Mauch, 1985, Reduction of fatal complications from combined modality therapy in Hodgkin's disease, Journal of Clinical Oncology, 3, 501, 10.1200/JCO.1985.3.4.501 McKenna, 1993, Workgroup #2: insurance and employability, Cancer, 2414, 10.1002/1097-0142(19930401)71:7<2414::AID-CNCR2820710738>3.0.CO;2-B Meadows, 1989, Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors, Medical and Pediatric Oncology, 17, 477, 10.1002/mpo.2950170525 Mellemkjœr, 1995, Cancer risk following splenectomy, Cancer, 75, 577, 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K Morgan, 1985, Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease, International Journal of Radiation Oncology Biology and Physics, 11, 1925, 10.1016/0360-3016(85)90273-1 National Research Council, 1980 National Research Council, 1990 Oberlin, 1995, Second malignant neoplasms after childhood Hodgkin's disease, 65 Ortin, 1990, Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience, International Journal of Radiation Oncology Biology and Physics, 19, 873, 10.1016/0360-3016(90)90007-7 Parkin, 1992 Peerboom, 1992, Thyroid function 10–18 years after mantle field irradiation for Hodgkin's disease, European Journal of Cancer, 28A, 1716, 10.1016/0959-8049(92)90075-D Pohjola-Sintonen, 1987, Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease, Cancer, 60, 31, 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D Redman, 1990, Therapy-related thyroid and parathyroid dysfunction in patients with Hodgkin's disease, 222 Redman, 1990, Hodgkin's disease: pregnancy and progeny, 244 Robinette, 1977, Splenectomy and subsequent mortality in veterans of the 1939–1945 war, Lancet, ii, 127, 10.1016/S0140-6736(77)90132-5 Robison, 1993, Second tumors after treatment of childhood malignancies, Hematology/Oncology Clinics of North America, 7, 389, 10.1016/S0889-8588(18)30248-X Rodriguez, 1993, Hodgkin's disease: study of treatment intensities and incidence of second malignancies, Annals of Oncology, 4, 125, 10.1093/oxfordjournals.annonc.a058414 Rubin, 1986, Hodgkin's disease: is there a price for successful treatment? A 25-year experience, International Journal of Radiation Oncology Biology and Physics, 12, 153, 10.1016/0360-3016(86)90088-X Santoro, 1987, Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy, Journal of Clinical Oncology, 5, 27, 10.1200/JCO.1987.5.1.27 Savage, 1990, Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease, International Journal of Radiation Oncology Biology and Physics, 19, 721, 10.1016/0360-3016(90)90502-B Schraub, 1982, Professional rehabilitation of cancer patients after treatment, Bulletin du Cancer (Paris), 69, 393 Sherins, 1993, Gonadal dysfunction, Vol. 2, 2395 Siegel, 1990, Hodgkin's disease survivorship: psychosocial consequences, 383 Smith, 1990, The skeletal system, 182 Swerdlow, 1992, Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation, British Medical Journal, 304, 1137, 10.1136/bmj.304.6835.1137 Swerdlow, 1993, Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy, British Journal of Cancer, 68, 1006, 10.1038/bjc.1993.470 Tarbell, 1990, Pulmonary complications of Hodgkin's disease treatment: radiation pneumonitis, fibrosis, and the effect of cytotoxic drugs, 296 Tarbell, 1993, Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood, Lancet, 341, 1428, 10.1016/0140-6736(93)90880-P Teta, 1986, Psychosocial consequences of childhood and adolescent cancer survival, Journal of Chronic Disease, 39, 751, 10.1016/0021-9681(86)90158-X Tucker, 1993, Solid second cancers following Hodgkin's disease, Hematology/Oncology Clinics of North America, 7, 389, 10.1016/S0889-8588(18)30247-8 Tucker, 1993, Secondary cancers, vol 2, 2407 Tucker, 1987, Leukemia after therapy with alkylating agents for childhood cancer, Journal of the National Cancer Institute, 78, 459, 10.1093/jnci/78.3.459 Tucker, 1988, Risk of secondary malignancies following Hodgkin's disease after 15 years, New England Journal of Medicine, 318, 76, 10.1056/NEJM198801143180203 Urba, 1992, Hodgkin's disease, New England Journal of Medicine, 326, 678, 10.1056/NEJM199203053261006 Valagussa, 1993, Hodgkin's disease and second malignancies, Annals of Oncology, 4, 94, 10.1093/oxfordjournals.annonc.a058443 van der Velden, 1988, Subsequent development of acute nonlymphocytic leukemia in patients treated for Hodgkin's disease, International Journal of Cancer, 42, 252, 10.1002/ijc.2910420218 van Leeuwen, 1987, Splenectomy in Hodgkin's disease and second leukaemias, Lancet, ii, 210, 10.1016/S0140-6736(87)90782-3 van Leeuwen, 1994, Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage, Journal of Clinical Oncology, 12, 1063, 10.1200/JCO.1994.12.5.1063 van Leeuwen, 1994, Second cancer risk following Hodgkin's disease: a 20-year follow-up study, Journal of Clinical Oncology, 12, 312, 10.1200/JCO.1994.12.2.312 van Rijswijk, 1987, Major complications and causes of death in patients treated for Hodgkin's disease, Journal of Clinical Oncology, 5, 1624, 10.1200/JCO.1987.5.10.1624 van Tulder, 1994, The quality of life of long term survivors of Hodgkin's disease, Annals of Oncology, 5, 153, 10.1093/oxfordjournals.annonc.a058768 Vaughan Hudson, 1994, Late mortality in young patients cured of Hodgkin's disease, Annals of Oncology, 5, S65, 10.1093/annonc/5.suppl_2.S65 Wasserman, 1987, The psychological status of survivors of childhood/adolescent Hodgkin's disease, American Journal of Disease in Children, 141, 626 Yellen, 1993, Quality of life in people with Hodgkin's disease, Oncology, 7, 41 Young, 1990, Late complications of Hodgkin's disease management, Journal of the National Cancer Institute Monograph, 10, 55 Zarrabi, 1989, Second neoplasms in Hodgkin's disease: current controversies, Hematology/Oncology Clinics of North America, 3, 303, 10.1016/S0889-8588(18)30558-6 Zeltzer, 1993, Cancer in adolescents and young adults psychosocial aspects: long term survivors, Cancer, 71, 3463, 10.1002/1097-0142(19930515)71:10+<3463::AID-CNCR2820711753>3.0.CO;2-B Zucali, 1981, Radiological and spirometric evaluation of mediastinal and pulmonary late effects after radiotherapy and chemotherapy for Hodgkin's disease, European Journal of Radiotherapy (Paris), 2, 169